Last updated on October 2020

Dupilumab Asthma Sleep Study


Brief description of study

Primary Objective:

To assess the effect of dupilumab on sleep

Secondary Objectives:

  • To evaluate the effect of dupilumab on additional patient reported sleep outcomes
  • To evaluate the effect of dupilumab on objective sleep assessment
  • To evaluate the effect of dupilumab on asthma symptoms
  • To evaluate the effect of dupilumab on lung function
  • To evaluate the safety of dupilumab

Detailed Study Description

Study duration per participant will be approximately 16 weeks and up to 29 weeks including up to 5 weeks screening period, a 12-week treatment period and up to 12 weeks post-treatment follow-up period

Clinical Study Identifier: NCT04502862

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.